Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/06
End: 01/31/09
Due: 01/31/10
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 05/31/14
Due: 05/31/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma | NCT00354926 | Applied Molecular Evolution | user2@example.com | None | 2006-07-31 | 2009-01-31 | 2010-01-31 | - | - | 2025-07-14 |
| A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib | NCT00689507 | Applied Molecular Evolution | user2@example.com | None | 2008-03-31 | 2014-05-31 | 2015-05-31 | - | - | 2025-07-14 |